Long-Term Clinical Outcomes of Entecavir and .tenofovir in Hepatitis B Cirrhosis
dc.contributor.author | Köklü, Seyfettin | |
dc.contributor.author | Tuna, Yaşar | |
dc.contributor.author | Gülşen, Murat T. | |
dc.contributor.author | Demir, Mehmet | |
dc.contributor.author | Köksal, Aydın S. | |
dc.contributor.author | Kockar, Muhammed C. | |
dc.contributor.author | Aygün, Cem | |
dc.date.accessioned | 2020-03-26T18:30:48Z | |
dc.date.available | 2020-03-26T18:30:48Z | |
dc.date.issued | 2012 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description | 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MA | en_US |
dc.description.abstract | [Abstract not Available] | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.identifier.citation | Köklü, S., Tuna, Y., Gülşen, M. T., Demir, M., Köksal, A. S., Kockar, M. C., Aygün, C., (2012). Long-Term Clinical Outcomes of Entecavir and .tenofovir in Hepatitis B Cirrhosis. Hepatology, (56), 383A-383A. | |
dc.identifier.endpage | 383A | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.startpage | 383A | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/28197 | |
dc.identifier.volume | 56 | en_US |
dc.identifier.wos | WOS:000310955601389 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley-Blackwell | en_US |
dc.relation.ispartof | Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.title | Long-Term Clinical Outcomes of Entecavir and .tenofovir in Hepatitis B Cirrhosis | en_US |
dc.type | Conference Object | en_US |